Company & Sponsor Intelligence

Ludwig-Maximilians - University of Munich

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials11

Recruiting3

Completed3

Countries2

Therapeutic footprint

alzheimersdepressionepilepsymigraine_headacheother_neurologystroke

Indexed studies

NCT00471744HEAD-Study Optimizing the Treatment of Children With BECTS
epilepsy · GermanyPHASE3

NCT05317871Clearance Mechanisms in Atypical Neurodegenerative Diseases
other_neurology · GermanyUNKNOWN

NCT03507400Introvision for Migraine and Headaches
migraine_headache · GermanyNA

NCT04080817Neolexon® Aphasia-App in Acute Aphasia After Stroke
stroke · GermanyNA

NCT06224920Activity of Cerebral Networks, Amyloid and Microglia in Aging and Alzheimer's Disease
alzheimers · COMPLETED

NCT05172505Transcranial Direct Current Stimulation in a Home Treatment Setting for Major Depression
depression · GermanyNA

NCT07586150Personalized Pharmaco-Lifestyle Interventions for Severe Mental Illnesses (LIFETRAIN)
depression · AustriaNA

NCT06711952German Validation Study of the Subjective Cognitive Decline Questionnaire (SCD-Q)
alzheimers · GermanyNA

NCT05059158Amyloid-β Clearance Mechanisms in Alzheimer's Disease
alzheimers · GermanyRECRUITING

NCT06191952Davos Alzheimer's Collaborative Healthcare System Preparedness to Increase Cognitive Assessment Rates for Older Adults
alzheimers · GermanyNA

NCT00145132Beta-CIT-SPECT and Neurophysiology in Depression
depression · GermanyPHASE4

Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →